DCF Tool


Nature`s Sunshine Products, Inc. – Pharmaceutical Preparation Manufacturing
Nature's Sunshine Products, a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today.
Analysis Results
Intrinsic Value $0.00
Latest Price $8.58
Relative Value 62741822% overvalued
Thoughts on this result? Let us know.
Cash Flow (Millions)
Analysis Parameters
New Ticker
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of -70.1%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 6.4%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of -70.1%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (million) Present value (million)
2022 0.000183 0.000172
2023 5.47e-05 4.83e-05
2024 1.64e-05 1.36e-05
2025 4.9e-06 3.82e-06
2026 1.47e-06 1.07e-06
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 3.4e-05 million. This corresponds to a present value of 2.35e-05 million.

Intrinsic Value Per Share

The total present value of the projected cash flows is 0.000239 million. Adding in the terminal value gives a total present value of 0.000262 million.

There are presently 19.2 million outstanding shares, so the intrinsic value per share is 0.0.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 164,667,000
Current Cash 86,184,000
Current Liabilities 76,670,000
Current Debt 1,546,000
Non-Cash Working Capital (NCWC) 3,359,000
Change in NCWC 8,511,000
EBIT 34,670,000
Tax Provision 1,615,000
Depreciation and Amortization 11,162,000
Capital Expenditure -6,666,000
Unlevered Free Cash Flow 45,917,461
Current Assets 154,065,000
Current Cash 92,069,000
Current Liabilities 69,654,000
Current Debt 2,506,000
Non-Cash Working Capital (NCWC) -5,152,000
Change in NCWC -7,799,000
EBIT 21,482,000
Tax Provision -137,000
Depreciation and Amortization 10,743,000
Capital Expenditure -4,905,000
Unlevered Free Cash Flow 19,521,000
Current Assets 112,705,000
Current Cash 53,629,000
Current Liabilities 57,947,000
Current Debt 1,518,000
Non-Cash Working Capital (NCWC) 2,647,000
Change in NCWC 11,617,000
EBIT 16,125,000
Tax Provision 8,713,000
Depreciation and Amortization 10,599,000
Capital Expenditure -5,104,000
Unlevered Free Cash Flow 24,254,956
Current Assets 106,825,000
Current Cash 50,638,000
Current Liabilities 66,687,000
Current Debt 1,530,000
Non-Cash Working Capital (NCWC) -8,970,000
Change in NCWC -15,418,000
EBIT 5,351,000
Tax Provision 4,402,000
Depreciation and Amortization 9,806,000
Capital Expenditure -4,834,000
Unlevered Free Cash Flow -9,497,000
Current Assets 102,509,000
Current Cash 42,910,000
Current Liabilities 53,657,000
Current Debt 506,000
Non-Cash Working Capital (NCWC) 6,448,000
Change in NCWC -6,497,000
EBIT 1,387,000
Tax Provision 17,039,000
Depreciation and Amortization 8,634,000
Capital Expenditure -5,501,000
Unlevered Free Cash Flow -19,016,000
Current Assets 100,121,000
Current Cash 34,060,000
Current Liabilities 63,035,000
Current Debt 9,919,000
Non-Cash Working Capital (NCWC) 12,945,000
Change in NCWC 5,059,000
EBIT 10,039,000
Tax Provision 8,591,000
Depreciation and Amortization 4,808,000
Capital Expenditure -11,537,000
Unlevered Free Cash Flow -938,689
Current Assets 101,518,000
Current Cash 43,192,000
Current Liabilities 53,136,000
Current Debt 2,696,000
Non-Cash Working Capital (NCWC) 7,886,000
Change in NCWC 5,791,000
EBIT 13,872,000
Tax Provision 1,740,000
Depreciation and Amortization 4,525,000
Capital Expenditure -22,527,000
Unlevered Free Cash Flow -156,566
Current Assets 121,249,000
Current Cash 61,245,000
Current Liabilities 57,909,000
Current Debt 0
Non-Cash Working Capital (NCWC) 2,095,000
Change in NCWC -944,000
EBIT 19,048,000
Tax Provision -743,000
Depreciation and Amortization 4,409,000
Capital Expenditure -26,285,000
Unlevered Free Cash Flow -3,772,000
Current Assets 148,594,000
Current Cash 79,253,000
Current Liabilities 68,569,000
Current Debt 2,267,000
Non-Cash Working Capital (NCWC) 3,039,000
Change in NCWC -2,942,000
EBIT 24,057,000
Tax Provision 8,044,000
Depreciation and Amortization 4,466,000
Capital Expenditure -8,570,000
Unlevered Free Cash Flow 9,467,457
Current Assets 145,333,000
Current Cash 81,312,000
Current Liabilities 61,390,000
Current Debt 3,350,000
Non-Cash Working Capital (NCWC) 5,981,000
Change in NCWC 10,026,000
EBIT 34,016,000
Tax Provision 10,116,000
Depreciation and Amortization 4,078,000
Capital Expenditure -6,629,000
Unlevered Free Cash Flow 31,796,784

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.